The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001114753.3(ENG):c.1807G>A (p.Gly603Arg)

CA374971982

995600 (ClinVar)

Gene: ENG (HGNC:2022)
Condition: telangiectasia, hereditary hemorrhagic, type 1 (MONDO:0008535)
Inheritance Mode: Autosomal dominant inheritance
UUID: 6086f2c6-c9b6-4fd8-b1fd-3342e29a7476
Approved on: 2024-11-12
Published on: 2024-11-15

HGVS expressions

NM_001114753.3:c.1807G>A
NM_001114753.3(ENG):c.1807G>A (p.Gly603Arg)
NC_000009.12:g.127815988C>T
CM000671.2:g.127815988C>T
NC_000009.11:g.130578267C>T
CM000671.1:g.130578267C>T
NC_000009.10:g.129618088C>T
NG_009551.1:g.43781G>A
NG_023245.1:g.18114C>T
ENST00000480266.6:c.1261G>A
ENST00000373203.9:c.1807G>A
ENST00000344849.4:c.1807G>A
ENST00000373203.8:c.1807G>A
ENST00000480266.5:c.1261G>A
NM_000118.3:c.1807G>A
NM_001114753.2:c.1807G>A
NM_001278138.1:c.1261G>A
NM_001278138.2:c.1261G>A
More

Likely Pathogenic

Met criteria codes 3
PM2_Supporting PS4 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Hemorrhagic Telangiectasia Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ENG Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Hemorrhagic Telangiectasia VCEP
The NM_001114753.3: c.1807G>A variant in ENG is a missense variant predicted to cause substitution of glycine by arginine at amino acid 603 (p.Gly603Arg). This variant has been reported in 4 probands with a phenotype consistent with Hereditary Hemorrhagic Telangiectasia (PS4, Internal lab contributors, PMID: 20414677). This variant is absent from gnomAD v.2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.876 which is above the threshold of 0.644, evidence that correlates with impact to ENG function (PP3). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PS4, PM2_Supporting, PP3 (specifications version 1.1.0; 11/12/2024).
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v.2.1.1 (PM2_Supporting).
PS4
This variant has been reported in 4 probands with a phenotype consistent with Hereditary Hemorrhagic Telangiectasia (PS4, Internal lab contributors, PMID: 20414677).
PP3
The computational predictor REVEL gives a score of 0.876 which is above the threshold of 0.644, evidence that correlates with impact to ENG function (PP3).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.